{"id":"NCT01574612","sponsor":"Meda Pharmaceuticals","briefTitle":"Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old","officialTitle":"An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-03","primaryCompletion":"2012-12","completion":"2013-02","firstPosted":"2012-04-10","resultsPosted":"2014-05-22","lastUpdate":"2014-05-22"},"enrollment":54,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Herpes Labialis"],"interventions":[{"type":"DRUG","name":"acyclovir/hydrocortisone cream","otherNames":["Xerese(r)"]}],"arms":[{"label":"topical cream acyclovir/hydrocortisone","type":"EXPERIMENTAL"}],"summary":"To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment.","primaryOutcome":{"measure":"Reporting of Adverse Events","timeFrame":"day 1 to day 21","effectByArm":[{"arm":"Topical Cream","deltaMin":9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":6},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":54},"commonTop":["URI","lip injury","general disorder","paresthesia oral","rash"]}}